Kestra Medical Technologies Inc
NASDAQ:KMTS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kestra Medical Technologies Inc
NASDAQ:KMTS
|
US |
|
Intrusion Inc
NASDAQ:INTZ
|
US |
|
Ootoya Holdings Co Ltd
TSE:2705
|
JP |
|
N
|
Nahar Capital and Financial Services Ltd
NSE:NAHARCAP
|
IN |
|
Sunopta Inc
F:ZSK
|
US |
|
C
|
Crystal Growth&Energy Equipment Co Ltd
SSE:688478
|
CN |
|
Y
|
Yau Lee Holdings Ltd
HKEX:406
|
HK |
|
N
|
Noront Resources Ltd
F:NQ1
|
CA |
|
Jabal Omar Development Company SJSC
SAU:4250
|
SA |
|
SPI Energy Co Ltd
NASDAQ:SPI
|
HK |
|
St Joe Co
NYSE:JOE
|
US |
|
M
|
Memiontec Holdings Ltd
SGX:TWL
|
SG |
|
I
|
IREIT Global
SGX:UD1U
|
SG |
|
B
|
BioMaxima SA
WSE:BMX
|
PL |
|
M
|
Mytilineos SA
ATHEX:MYTIL
|
GR |
|
S
|
SinoCloud Group Ltd
SGX:5EK
|
HK |
|
Dixon Technologies (India) Ltd
BSE:540699
|
IN |
|
Genting Malaysia Bhd
OTC:GMALF
|
MY |
|
Jefferies Financial Group Inc
NYSE:JEF
|
US |
Balance Sheet
Balance Sheet Decomposition
Kestra Medical Technologies Inc
Kestra Medical Technologies Inc
Balance Sheet
Kestra Medical Technologies Inc
| Apr-2021 | Apr-2023 | Apr-2024 | Apr-2025 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
24
|
15
|
8
|
238
|
|
| Cash Equivalents |
24
|
15
|
8
|
238
|
|
| Total Receivables |
0
|
0
|
2
|
8
|
|
| Accounts Receivables |
0
|
0
|
2
|
8
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
2
|
4
|
5
|
10
|
|
| Total Current Assets |
26
|
18
|
15
|
255
|
|
| PP&E Net |
3
|
17
|
28
|
37
|
|
| PP&E Gross |
3
|
17
|
28
|
37
|
|
| Accumulated Depreciation |
2
|
7
|
18
|
24
|
|
| Other Long-Term Assets |
1
|
4
|
3
|
4
|
|
| Total Assets |
31
N/A
|
39
+27%
|
46
+19%
|
296
+544%
|
|
| Liabilities | |||||
| Accounts Payable |
2
|
6
|
24
|
24
|
|
| Accrued Liabilities |
5
|
10
|
9
|
14
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
20
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
7
|
37
|
33
|
38
|
|
| Long-Term Debt |
20
|
17
|
43
|
41
|
|
| Other Liabilities |
2
|
0
|
3
|
11
|
|
| Total Liabilities |
29
N/A
|
54
+88%
|
78
+45%
|
90
+15%
|
|
| Equity | |||||
| Common Stock |
0
|
102
|
177
|
51
|
|
| Retained Earnings |
170
|
312
|
406
|
520
|
|
| Additional Paid In Capital |
172
|
195
|
197
|
674
|
|
| Total Equity |
2
N/A
|
15
N/A
|
32
-109%
|
205
N/A
|
|
| Total Liabilities & Equity |
31
N/A
|
39
+27%
|
46
+19%
|
296
+544%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
50
|
50
|
50
|
50
|
|